5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part B

Part 1: Serotonin in the CNS 1. The multiple facets of serotonergic modulation on brain functions Giuseppe Di Giovanni 2. Anatomical and neurochemical organization of the serotonergic system in the mammalian brain Harry Steinbusch 3. 5-HT2A/2C Receptors in the Brain Cristiano Bombardi

Part 2: Serotonin-dopamine interactions 4. Electrophysiological and neurochemical bases for an interaction of serotonin on central dopaminergic neurons Giuseppe Di Giovanni 5. The complex nature of serotonin-dopamine neurons interaction in primate model of Parkinson's disease Veronique Sgambato 6. The status of serotonergic system in presymptomatic and symptomatic stages of Huntington disease and corresponding animal models Anthony Hannan 7. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias Manolo Carta 8. The serotonergic agent L-DOPA in the treatment of Parkinson's disease Marios Politis

Part 3: Serotonin-Glutamate interaction 9. Cortical influences of serotonin on pyramidal cells Gerard Joseph Marek 10. The interaction of serotonin with noradrenergic, dopaminergic, cholinergic, and opioid systems in Alzheimer's disease Goran Simic 11. Serotonergic controls upon the glutamatergic neurons of the subthalamic nucleus Luisa Ugedo

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Neurociências
• Fisiológico e neuro-psicologia, biopsicologia

2-AG; 5-HT; 5-HT receptors; 5-HT2A receptor; 5-HT2A receptors; 5-HT2C receptor; Adrenoceptors; Adult neurogenesis; Anandamide; Antidepressant astrocytes; Anxiety; Cannabinoid; CB1 receptor; CB1 receptors; Critical period; Depression; Drug addiction; Eating disorder; Endocannabinoid; Endocannabinoid system; epilepsy; Epilepsy; Feeding; GABA; GABAA receptors; GABAergic; Glial cell; Gliotransmitters; Locus coeruleus; Lorcaserin; Mental disorders; Monotherapy to polytherapy; Neurodevelopment; Neuropsychiatric disorders; Nicotine; Noradrenaline; Noradrenergic; Obesity; Pharmacotherapy; Pimavanserin; Plasticity; Psilocybin; Psychedelics; Psychosis; Raphe nuclei; Schizophrenia; Serotonergic neurotransmission; Serotonin; Smoking cessation; Somatosensory cortex; Visual cortex